RemeGen Co., Ltd. (FRA:REG)
Germany · Delayed Price · Currency is EUR 8.85
+0.05 (0.57%)
At close: Jan 30, 2026
RemeGen Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,221 | 1,710 | 1,076 | 767.78 | 1,424 | - |
Other Revenue | 6.71 | 6.71 | 6.82 | 4.33 | - | - |
| 2,228 | 1,717 | 1,083 | 772.11 | 1,424 | - | |
Revenue Growth (YoY) | 46.34% | 58.54% | 40.26% | -45.77% | - | - |
Cost of Revenue | 372.57 | 346.72 | 257.27 | 272.05 | 67.16 | - |
Gross Profit | 1,855 | 1,370 | 825.68 | 500.06 | 1,357 | - |
Selling, General & Admin | 1,446 | 1,265 | 1,079 | 707.01 | 482.81 | 241.8 |
Research & Development | 1,277 | 1,540 | 1,306 | 982.08 | 710.97 | 465.82 |
Other Operating Expenses | 38.14 | -14.92 | -22.56 | -13.53 | 41.23 | 3.78 |
Operating Expenses | 2,764 | 2,795 | 2,371 | 1,686 | 1,235 | 711.46 |
Operating Income | -908.63 | -1,425 | -1,545 | -1,186 | 121.61 | -711.46 |
Interest Expense | -73.82 | -72.38 | -23.09 | -6.76 | -5.32 | -29.23 |
Interest & Investment Income | 4.02 | 10.24 | 35.12 | 73.65 | 43.35 | 1.94 |
Currency Exchange Gain (Loss) | -7.13 | -7.13 | 1.53 | 13.23 | -25.47 | -32.33 |
Other Non Operating Income (Expenses) | 8.1 | -6.79 | -4.58 | -0.77 | 142.62 | 73.45 |
EBT Excluding Unusual Items | -977.46 | -1,501 | -1,536 | -1,107 | 276.79 | -697.62 |
Gain (Loss) on Sale of Investments | -9.4 | -4.29 | - | - | -0.22 | - |
Gain (Loss) on Sale of Assets | 0.73 | 0.61 | -0.79 | -1.02 | -0.31 | -0.21 |
Other Unusual Items | 28.51 | 36.07 | 25.97 | 108.84 | 0 | 0.01 |
Pretax Income | -947.63 | -1,468 | -1,511 | -998.83 | 276.26 | -697.82 |
Net Income | -947.63 | -1,468 | -1,511 | -998.83 | 276.26 | -697.82 |
Net Income to Common | -947.63 | -1,468 | -1,511 | -998.83 | 276.26 | -697.82 |
Shares Outstanding (Basic) | 543 | 538 | 540 | 531 | 487 | 408 |
Shares Outstanding (Diluted) | 543 | 538 | 540 | 531 | 487 | 408 |
Shares Change (YoY) | 0.77% | -0.34% | 1.59% | 9.00% | 19.43% | 56.70% |
EPS (Basic) | -1.75 | -2.73 | -2.80 | -1.88 | 0.57 | -1.71 |
EPS (Diluted) | -1.75 | -2.73 | -2.80 | -1.88 | 0.57 | -1.71 |
Free Cash Flow | -322.69 | -1,380 | -2,356 | -2,013 | -351.44 | -1,104 |
Free Cash Flow Per Share | -0.59 | -2.56 | -4.36 | -3.79 | -0.72 | -2.70 |
Gross Margin | 83.28% | 79.81% | 76.24% | 64.77% | 95.28% | - |
Operating Margin | -40.79% | -82.98% | -142.70% | -153.61% | 8.54% | - |
Profit Margin | -42.54% | -85.53% | -139.55% | -129.36% | 19.40% | - |
Free Cash Flow Margin | -14.48% | -80.36% | -217.51% | -260.74% | -24.68% | - |
EBITDA | -636.46 | -1,194 | -1,369 | -1,062 | 187.84 | -661.56 |
EBITDA Margin | -28.57% | -69.53% | -126.44% | -137.54% | 13.19% | - |
D&A For EBITDA | 272.18 | 231.01 | 176.12 | 124.03 | 66.24 | 49.89 |
EBIT | -908.63 | -1,425 | -1,545 | -1,186 | 121.61 | -711.46 |
EBIT Margin | -40.79% | -82.98% | -142.70% | -153.61% | 8.54% | - |
Revenue as Reported | 2,228 | 1,717 | 1,083 | 772.11 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.